Tag: Biomarkers

Oncotarget News

Oncotarget | Predictive Molecular Biomarkers for Determining Neoadjuvant Chemosensitivity in Muscle Invasive Bladder Cancer

November 8, 2022

To our knowledge, our study is the first to use combined differential mRNA and miRNA expression in MIBC to identify a NAC response signature.”BUFFALO, NY- November 8, 2022 – A... read more

Dr. Glenn Simmons Jr. and Dr. Stefani Thomas

Oncotarget

Behind the Study: Targeting Lipid Metabolism in Treatment of Ovarian Cancer

September 12, 2022

Dr. Glenn Simmons Jr. from Cornell University College of Veterinary Medicine, and Dr. Stefani Thomas from University of Minnesota School of Medicine, detail a recent review they co-authored that was... read more

Oncotarget

Behind the Study: Molecular Characterization of Lung Carcinomas Expressing KK-LC-1

July 11, 2022

Dr. Robert Hsu from the University of Southern California, Norris Comprehensive Cancer Center, describes a recent research paper he co-authored that was published by Oncotarget, entitled, “Molecular characterization of... read more

Oncotarget

Behind the Study: IGF-pathway Biomarkers and Lung Cancer

June 14, 2022

Dr. Alexander Pohlman from Rush Medical College, Rush University Medical Center, Chicago, IL, describes a recent review published by Oncotarget that he co-authored entitled, “The role of IGF-pathway biomarkers in... read more

Oncotarget

Behind the Study: P4HA1 Protein and Colorectal Cancer

November 22, 2021

Dr. Michael Roehrl from Memorial Sloan Kettering Cancer Center describes the research paper he co-authored that was published by Oncotarget on February 25, 2020, entitled, “Prolyl 4-hydroxylase... read more